Total Payments
$68,500
2024 Payments
$3,788
Companies
57
Transactions
1,291
Medicare Patients
11,111
Medicare Billing
$2.0M
Payment Breakdown by Category
Consulting$35,180 (51.4%)
Food & Beverage$23,955 (35.0%)
Other$5,767 (8.4%)
Travel$3,528 (5.2%)
Education$70.05 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,180 | 5 | 51.4% |
| Food and Beverage | $23,955 | 1,267 | 35.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,767 | 5 | 8.4% |
| Travel and Lodging | $3,528 | 8 | 5.2% |
| Education | $70.05 | 6 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Philips Electronics North America Corporation | $34,587 | 16 | $0 (2023) |
| GE HEALTHCARE | $6,947 | 7 | $0 (2024) |
| Boston Scientific Corporation | $6,226 | 116 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,333 | 150 | $0 (2024) |
| BIOTRONIK INC. | $2,145 | 27 | $0 (2024) |
| Amgen Inc. | $1,942 | 127 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,713 | 114 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,386 | 77 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $1,380 | 86 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $1,349 | 104 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,788 | 135 | GE HEALTHCARE ($1,194) |
| 2023 | $4,451 | 144 | Boston Scientific Corporation ($1,653) |
| 2022 | $37,010 | 178 | Philips Electronics North America Corporation ($32,177) |
| 2021 | $9,019 | 203 | GE HEALTHCARE ($3,688) |
| 2020 | $2,785 | 145 | Janssen Pharmaceuticals, Inc ($466.47) |
| 2019 | $5,756 | 167 | Boston Scientific Corporation ($2,429) |
| 2018 | $2,683 | 147 | BIOTRONIK INC. ($808.69) |
| 2017 | $3,009 | 172 | United Therapeutics Corporation ($485.90) |
All Payment Transactions
1,291 individual payment records from CMS Open Payments — Page 1 of 52
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/11/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Cardiology | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: WATCHMAN_IC | ||||||
| 12/04/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: WATCHMAN_IC | ||||||
| 12/03/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.62 | General |
| Category: Cardiovascular | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: WATCHMAN_IC | ||||||
| 11/13/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $27.60 | General |
| Category: WATCHMAN_IC | ||||||
| 11/12/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Cardiology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.62 | General |
| 11/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Cardio-renal | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Obesity | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: DIABETES | ||||||
| 10/22/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $26.83 | General |
| Category: WATCHMAN_IC | ||||||
| 10/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiology | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Cardiology | ||||||
| 10/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,192 | 3,307 | $985,731 | $285,560 |
| 2022 | 30 | 2,512 | 3,960 | $1.3M | $423,792 |
| 2021 | 34 | 3,054 | 4,947 | $2.1M | $727,786 |
| 2020 | 35 | 3,353 | 5,379 | $1.8M | $597,724 |
Total Patients
11,111
Total Services
17,593
Medicare Billing
$2.0M
Procedure Codes
134
All Medicare Procedures & Services
134 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 446 | 741 | $133,215 | $61,299 | 46.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 262 | 267 | $201,511 | $35,729 | 17.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 111 | 111 | $90,295 | $34,790 | 38.5% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 111 | 219 | $88,195 | $29,683 | 33.7% |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | Office | 2023 | 51 | 284 | $111,328 | $15,164 | 13.6% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 79 | 81 | $45,765 | $13,940 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 170 | 194 | $22,606 | $10,670 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 76 | $18,220 | $9,187 | 50.4% |
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 14 | 15 | $34,526 | $6,557 | 19.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 37 | 148 | $18,464 | $6,504 | 35.2% |
| 93924 | Ultrasound of leg arteries at rest and after exercise | Office | 2023 | 78 | 80 | $26,000 | $6,472 | 24.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 61 | 102 | $13,308 | $6,291 | 47.3% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 45 | 45 | $23,988 | $5,791 | 24.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 110 | 111 | $16,970 | $5,148 | 30.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 23 | 23 | $22,177 | $4,143 | 18.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $11,084 | $4,073 | 36.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 33 | 33 | $8,427 | $3,334 | 39.6% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 45 | 56 | $10,352 | $3,005 | 29.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $6,736 | $2,541 | 37.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 24 | 141 | $10,575 | $2,490 | 23.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $4,621 | $2,354 | 50.9% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 26 | 126 | $9,954 | $2,168 | 21.8% |
| 37252 | Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | Facility | 2023 | 22 | 27 | $6,524 | $1,854 | 28.4% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 48 | 57 | $6,555 | $1,829 | 27.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 13 | 17 | $3,093 | $1,583 | 51.2% |
About Dr. Andre Bouhasin, MD
Dr. Andre Bouhasin, MD is a Interventional Cardiology healthcare provider based in Farmington, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508808635.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andre Bouhasin, MD has received a total of $68,500 in payments from pharmaceutical and medical device companies, with $3,788 received in 2024. These payments were reported across 1,291 transactions from 57 companies. The most common payment nature is "Consulting Fee" ($35,180).
As a Medicare-enrolled provider, Bouhasin has provided services to 11,111 Medicare beneficiaries, totaling 17,593 services with total Medicare billing of $2.0M. Data is available for 4 years (2020–2023), covering 134 distinct procedure/service records.
Ad
Practice Information
- Specialty Interventional Cardiology
- Other Specialties Cardiovascular Disease
- Location Farmington, MO
- Active Since 06/12/2006
- Last Updated 12/03/2025
- Taxonomy Code 207RI0011X
- Entity Type Individual
- NPI Number 1508808635
Products in Payments
- (9520) IGT Devices Undivided (Device) $34,000
- WATCHMAN (Device) $2,770
- WATCHMAN Access System (Device) $2,472
- XARELTO (Drug) $2,346
- ENTRESTO (Drug) $1,459
- ELIQUIS (Drug) $1,250
- OEC (Device) $1,194
- ORENITRAM (Drug) $1,140
- Repatha (Biological) $1,017
- Corlanor (Drug) $883.00
- BRILINTA (Drug) $811.03
- LifeVest (Device) $740.11
- JARDIANCE (Drug) $670.29
- UPTRAVI (Drug) $628.72
- FARXIGA (Drug) $433.87
- OPSUMIT (Drug) $430.06
- GENERAL - VASCULAR INTERVENTION (Device) $392.33
- VERQUVO (Drug) $358.87
- Adempas (Drug) $354.59
- CAMZYOS (Drug) $324.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Interventional Cardiology Doctors in Farmington
Christopher Kim, Md, MD
Interventional Cardiology — Payments: $43,867
Interventional Cardiology $43,867
Dr. Stephen Bernard, M.d, M.D
Interventional Cardiology — Payments: $36,402
Interventional Cardiology $36,402
Dr. Sudhakar Girotra
Interventional Cardiology — Payments: $4,417
Interventional Cardiology $4,417
Stephen Mackerrow, M.d, M.D
Interventional Cardiology — Payments: $1,062
Interventional Cardiology $1,062